Equities Research Analysts’ Updated EPS Estimates for October 20th (ABVX, AMD, AMSF, AV, AZN, BMRN, BNZL, BRVE, CDNS, CYTK)

Equities Research Analysts’ updated eps estimates for Tuesday, October 20th:

Abivax (NASDAQ:ABVX) had its buy rating reiterated by analysts at Guggenheim. They currently have a $175.00 price target on the stock.

Advanced Micro Devices (NASDAQ:AMD) had its outperform rating reissued by analysts at Wedbush. They currently have a $600.00 price target on the stock.

AMERISAFE (NASDAQ:AMSF) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Aviva (LON:AV) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 694 target price on the stock.

AstraZeneca (LON:AZN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a £175 target price on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $86.00 price target on the stock.

Bunzl (LON:BNZL) had its underperform rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 2,300 target price on the stock.

Braveheart Bio (NASDAQ:BRVE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $40.00 target price on the stock.

Cadence Design Systems (NASDAQ:CDNS) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Cytokinetics (NASDAQ:CYTK) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $16.00 price target on the stock.

Elanco Animal Health (NYSE:ELAN) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a $24.00 target price on the stock, down from their previous target price of $31.00.

Equinix (NASDAQ:EQIX) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $1,235.00 target price on the stock.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its neutral rating reissued by analysts at Mizuho. Mizuho currently has a $0.50 price target on the stock.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co..

Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its neutral rating reissued by analysts at HC Wainwright.

GB Group (LON:GBG) had its speculative buy rating reissued by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 300 target price on the stock.

Genelux (NASDAQ:GNLX) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

GSK (LON:GSK) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 2,500 price target on the stock.

Heartland Express (NASDAQ:HTLD) had its neutral rating reaffirmed by analysts at Robert W. Baird. They currently have a $12.00 target price on the stock, down from their previous target price of $16.00.

Howden Joinery Group (LON:HWDN) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 847 target price on the stock.

Gartner (NYSE:IT) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $198.00 target price on the stock.

Live Nation Entertainment (NYSE:LYV) had its sell rating reiterated by analysts at Cfra.

Meta Platforms (NASDAQ:META) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $886.00 price target on the stock.

M&G (LON:MNG) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 370 price target on the stock.

MannKind (NASDAQ:MNKD) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $8.00 target price on the stock.

Mobia Medical (NASDAQ:MOBI) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $19.00 price target on the stock.

Myers Industries (NYSE:MYE) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Myriad Genetics (NASDAQ:MYGN) was upgraded by analysts at Piper Sandler from an underweight rating to a neutral rating. The firm currently has $5.00 target price on the stock.

Nucor (NYSE:NUE) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Procter & Gamble (NYSE:PG) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $166.00 price target on the stock.

Public Storage (NYSE:PSA) had its sector perform rating reissued by analysts at Royal Bank Of Canada. They currently have a $318.00 target price on the stock.

Rapport Therapeutics (NASDAQ:RAPP) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $66.00 target price on the stock.

Relx (NYSE:RELX) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating.

Banco Santander (NYSE:SAN) had its hold rating reissued by analysts at Jefferies Financial Group Inc..

Sabre Insurance Group (LON:SBRE) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 205 target price on the stock.

NuScale Power (NYSE:SMR) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. They currently have $5.00 price target on the stock.

Spotify Technology (NYSE:SPOT) had its neutral rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $527.00 price target on the stock.

Serica Energy (LON:SQZ) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 320 price target on the stock.

TKO Group (NYSE:TKO) was upgraded by analysts at Arete Research from a neutral rating to a buy rating. Arete Research currently has $208.00 target price on the stock.

Trifast (LON:TRI) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 140 price target on the stock.

Americas Gold and Silver (NYSEAMERICAN:USAS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $9.25 price target on the stock.

Vodafone Group (NASDAQ:VOD) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating.

Wickes Group (LON:WIX) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 250 price target on the stock.

Wickes Group (LON:WIX) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 260 target price on the stock.

Zions Bancorporation, N.A. (NASDAQ:ZION) had its sector perform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $76.00 price target on the stock.

Zions Bancorporation, N.A. (NASDAQ:ZION) had its hold rating reiterated by analysts at TD Cowen. The firm currently has a $69.00 price target on the stock.